254 related articles for article (PubMed ID: 24289183)
1. Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals.
Godbole G; Irish D; Basarab M; Mahungu T; Fox-Lewis A; Thorne C; Jacobs M; Dusheiko G; Rosenberg WM; Suri D; Millar AD; Nastouli E
BMC Pregnancy Childbirth; 2013 Dec; 13():222. PubMed ID: 24289183
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
3. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
[TBL] [Abstract][Full Text] [Related]
4. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
Mokaya J; Burn EAO; Tamandjou CR; Goedhals D; Barnes EJ; Andersson M; Pinedo-Villanueva R; Matthews PC
BMC Public Health; 2019 Jun; 19(1):829. PubMed ID: 31242901
[TBL] [Abstract][Full Text] [Related]
5. Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.
van Schalkwyk J; Nourmoussavi M; Massey A; Gustafson R; Brodkin E; Petric M; Krajden M; Dobson S; Buxton J; Bigham M; Pick N; Schreiber R; Sherlock CH; Money D; Yoshida EM
Can J Gastroenterol Hepatol; 2014 Nov; 28(10):525-8. PubMed ID: 25390612
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
[TBL] [Abstract][Full Text] [Related]
7. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
[TBL] [Abstract][Full Text] [Related]
8. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.
Lu Y; Song Y; Zhai X; Zhu F; Liu J; Chang Z; Li Y; Xiao Y; Li L; Liu M; Liu J; Duan Z; Zou H; Zhuang H; Wang J; Li J
Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609
[TBL] [Abstract][Full Text] [Related]
9. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.
Zhang L; Gui XE; Wang B; Fan JY; Cao Q; Mullane K; Liang XL
BMC Infect Dis; 2016 Aug; 16(1):408. PubMed ID: 27515176
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.
Han L; Zhang HW; Xie JX; Zhang Q; Wang HY; Cao GW
World J Gastroenterol; 2011 Oct; 17(38):4321-33. PubMed ID: 22090789
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
[TBL] [Abstract][Full Text] [Related]
12. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women.
Sun KX; Li J; Zhu FC; Liu JX; Li RC; Zhai XJ; Li YP; Chang ZJ; Nie JJ; Zhuang H
Vaccine; 2012 Aug; 30(36):5335-40. PubMed ID: 22749833
[TBL] [Abstract][Full Text] [Related]
13. Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience.
Chotun N; Preiser W; van Rensburg CJ; Fernandez P; Theron GB; Glebe D; Andersson MI
PLoS One; 2017; 12(7):e0181267. PubMed ID: 28732085
[TBL] [Abstract][Full Text] [Related]
14. Acceptance of antiviral treatment and enhanced service model for pregnant patients carrying hepatitis B.
Hui PW; Ng C; Cheung KW; Lai CL
Hong Kong Med J; 2020 Aug; 26(4):318-322. PubMed ID: 32801216
[TBL] [Abstract][Full Text] [Related]
15. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
Sellier PO; Maylin S; Berçot B; Chopin D; Lopes A; Simoneau G; Evans J; Delcey V; Bénifla JL; Simon F; Bergmann JF
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):259-263. PubMed ID: 27879486
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis.
Liu CP; Zeng YL; Zhou M; Chen LL; Hu R; Wang L; Tang H
Intern Med; 2015; 54(7):711-6. PubMed ID: 25832930
[TBL] [Abstract][Full Text] [Related]
17. Prenatal Screening for and Prevalence of Hepatitis B Surface Antigen in Pregnant Women and Prevention of Transmission to Infants Born to Infected Mothers-Guam, 2014.
Abara WE; Cha S; Malik T; DeSimone MS; Schillie S; Collier M; Schumann B; Klemme M; Kamb M
J Pediatric Infect Dis Soc; 2018 Dec; 7(4):290-295. PubMed ID: 28992071
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission.
Dwivedi M; Misra SP; Misra V; Pandey A; Pant S; Singh R; Verma M
Indian J Gastroenterol; 2011 Mar; 30(2):66-71. PubMed ID: 21499863
[TBL] [Abstract][Full Text] [Related]
19. A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission.
Zhang L; Gui X; Wang B; Ji H; Yisilafu R; Li F; Zhou Y; Zhang L; Zhang H; Liu X
Eur J Pediatr; 2014 Sep; 173(9):1161-8. PubMed ID: 24699981
[TBL] [Abstract][Full Text] [Related]
20. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
